Allergan Sales LLC

Form 483 issued July 29, 2019 · Cincinnati, Ohio

Investigator
Lauren N. Howard
Observations
4
Pages
8
FEI number
1523957

In short: On July 29, 2019, FDA issued a Form 483 with 4 observations to Allergan Sales LLC in Cincinnati, Ohio (FEI 1523957). The investigator was Lauren N. Howard. Most observations concern quality system and laboratory controls.

At a glance

Observations span 4 systems, led by quality system.

Quality system1
Laboratory controls1
Production1
Materials1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

  2. 02

    Laboratory controls do not include the establishment of scientifically sound and appropriate specifications designed to assure…

  3. 03

    Control procedures are not established which validate the performance of those manufacturing processes that may be…

  4. 04

    Approved components are not retested or reexamined as appropriate for identity, strength, quality and purity after…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Allergan Sales LLC?

FDA listed 4 observations on this Form 483, mostly about quality system, laboratory controls and production. The opening words of each observation are shown on this page.

Who inspected Allergan Sales LLC?

Lauren N. Howard is named on this Form 483. Each investigator has a profile showing what they cite most.

When was Allergan Sales LLC inspected by FDA?

This Form 483 is dated July 29, 2019.

How do I get the full Form 483 for Allergan Sales LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free